These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 37924464)

  • 1. Practical recommendations for antihypertensive therapy during the primary aldosteronism screening test.
    Li J; Yan H; Li L; Lin X; Zhao Z; Zhou C; Zhang Q
    Endocrine; 2024 Jan; 83(1):188-195. PubMed ID: 37924464
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison between screening for primary aldosteronism with and without drug adjustment.
    Hua Y; He Q
    Blood Press; 2024 May; 33(1):2350981. PubMed ID: 38824645
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How should anti-hypertensive medications be adjusted before screening for primary aldosteronism?
    Lu JY; Chang YY; Lee TW; Wu MH; Chen ZW; Huang YT; Lai TS; Er LK; Lin YH; Wu VC; Cheng HM; Kao HL; Jia-Yin Hou C; Wu KD; Chen ST; Liu FH
    J Formos Med Assoc; 2024 Mar; 123 Suppl 2():S91-S97. PubMed ID: 37291044
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Aldosterone-to-renin ratio threshold for screening primary aldosteronism in Chinese hypertensive patients].
    Chen SX; Du YL; Zhang J; Gong YC; Hu YR; Chu SL; He QB; Song YY; Zhu DL
    Zhonghua Xin Xue Guan Bing Za Zhi; 2006 Oct; 34(10):868-72. PubMed ID: 17217708
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of antihypertensive medication on aldosterone and renin concentration in the differential diagnosis of essential hypertension and primary aldosteronism.
    Seifarth C; Trenkel S; Schobel H; Hahn EG; Hensen J
    Clin Endocrinol (Oxf); 2002 Oct; 57(4):457-65. PubMed ID: 12354127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. β-Blocker withdrawal is preferable for accurate interpretation of the aldosterone-renin ratio in chronically treated hypertension.
    Browne GA; Griffin TP; O'Shea PM; Dennedy MC
    Clin Endocrinol (Oxf); 2016 Mar; 84(3):325-31. PubMed ID: 26300226
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Steroidomics-Based Screening for Primary Aldosteronism: Impact of antihypertensive Drugs.
    Constantinescu G; Gruber S; Fuld S; Peitzsch M; Schulze M; Remde H; Kürzinger L; Yang J; Yen T; Williams TA; Müller L; Reincke M; Lenders JWM; Beuschlein F; Pamporaki C; Eisenhofer GF
    Hypertension; 2024 Oct; 81(10):2060-2071. PubMed ID: 39082132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mineralocorticoid Receptor Antagonists Decrease the Rates of Positive Screening for Primary Aldosteronism.
    Tezuka Y; Turcu AF
    Endocr Pract; 2020 Dec; 26(12):1416-1424. PubMed ID: 33471733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of antihypertensive therapy with angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers in combination with calcium channel blockers for stroke prevention.
    Talbert RL
    J Am Pharm Assoc (2003); 2010; 50(5):e116-25. PubMed ID: 20833609
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HYT-hypertension in Turkey: a cross-sectional survey on blood pressure control with calcium channel blockers alone or combined with other antihypertensive drugs.
    Seravalle G; Koylan N; Nalbantgil I; Caglar N; Quarti-Trevano F; Makel W; Grassi G; Fici F
    High Blood Press Cardiovasc Prev; 2015 Jun; 22(2):165-72. PubMed ID: 25900022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnosis of primary aldosteronism: value of different screening parameters and influence of antihypertensive medication.
    Seiler L; Rump LC; Schulte-Mönting J; Slawik M; Borm K; Pavenstädt H; Beuschlein F; Reincke M
    Eur J Endocrinol; 2004 Mar; 150(3):329-37. PubMed ID: 15012618
    [TBL] [Abstract][Full Text] [Related]  

  • 12. First-line drugs inhibiting the renin angiotensin system versus other first-line antihypertensive drug classes for hypertension.
    Xue H; Lu Z; Tang WL; Pang LW; Wang GM; Wong GW; Wright JM
    Cochrane Database Syst Rev; 2015 Jan; 1():CD008170. PubMed ID: 25577154
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative risk of new-onset diabetes mellitus for antihypertensive drugs in elderly: A Bayesian network meta-analysis.
    Zhang J; Tong A; Dai Y; Niu J; Yu F; Xu F
    J Clin Hypertens (Greenwich); 2019 Aug; 21(8):1082-1090. PubMed ID: 31241860
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The benefits of angiotensin-converting enzyme inhibitors/angiotensin II receptor blockers combined with calcium channel blockers on metabolic, renal, and cardiovascular outcomes in hypertensive patients: a meta-analysis.
    Pongpanich P; Pitakpaiboonkul P; Takkavatakarn K; Praditpornsilpa K; Eiam-Ong S; Susantitaphong P
    Int Urol Nephrol; 2018 Dec; 50(12):2261-2278. PubMed ID: 30324578
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The cutoff value of aldosterone-to-renin ratio for the diagnosis of primary aldosteronism in patients taking antihypertensive medicine.
    Niizuma S; Nakahama H; Kamide K; Fukuchi K; Iwanaga Y; Nakata H; Yoshihara F; Horio T; Nakamura S; Kawano Y
    Clin Exp Hypertens; 2008 Oct; 30(7):640-7. PubMed ID: 18855267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RAS-challenge as a first-look test for detection of primary aldosteronism in patients with treatment-resistant hypertension.
    Beger C; Karg T; Hinrichs JB; Ringe B; Haller H; Meyer BC; Limbourg FP
    Blood Press; 2023 Dec; 32(1):2179340. PubMed ID: 36803263
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening for primary aldosteronism in a primary care unit.
    Volpe C; Wahrenberg H; Hamberger B; Thorén M
    J Renin Angiotensin Aldosterone Syst; 2013 Sep; 14(3):212-9. PubMed ID: 23118039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antihypertensive drug classes have different effects on short-term blood pressure variability in essential hypertension.
    Levi-Marpillat N; Macquin-Mavier I; Tropeano AI; Parati G; Maison P
    Hypertens Res; 2014 Jun; 37(6):585-90. PubMed ID: 24671016
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of calcium channels blockers and inhibitors of the renin-angiotensin system on renal outcomes and mortality in patients suffering from chronic kidney disease: systematic review and meta-analysis.
    Zhao HJ; Li Y; Liu SM; Sun XG; Li M; Hao Y; Cui LQ; Wang AH
    Ren Fail; 2016 Jul; 38(6):849-56. PubMed ID: 27055479
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of antihypertensive treatment using real-world Japanese data-the retrospective study of antihypertensives for lowering blood pressure (REAL) study.
    Ohishi M; Yoshida T; Oh A; Hiroi S; Takeshima T; Otsuka Y; Iwasaki K; Shimasaki Y
    Hypertens Res; 2019 Jul; 42(7):1057-1067. PubMed ID: 30842611
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.